BSE filing, BSE: 530217. Summary written from the filing by ALFA Finder's alert engine.
Swojas Foods Ltd: key numbers
- Share price
- ₹6.71
- Market cap
- ₹32.40 Cr
- Revenue (annual)
- ₹146.2 Cr
- Net profit (annual)
- ₹0.89 Cr
- P/E (TTM)
- 42.4×Sector 38.6×
- Promoter holding
- 0.40%-0.07% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Swojas Foods Ltd
All →Swojas Foods Board Meeting Date
Swojas Foods will hold its board meeting on 3 November 2026 to approve Q1 and H1 FY27 standalone financial results. No other material agenda items are listed.
Swojas Foods Convertible Warrants
Swojas Foods allotted 16,00,000 equity shares on conversion of preferential warrants held by Onelife Capital Advisors, a non-promoter. Cash of Rs 1.98 Crore was received, raising paid-up capital to Rs 498.88 Crore.
- Value
- ₹1.98 Cr
Swojas Foods Other Announcement
Swojas Foods Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, noting recent equity share allotments upon warrant conversion.
Swojas Foods Capital Structure Change
Onelife Capital Advisors Limited acquired 24,25,000 equity shares of Swojas Foods Limited upon conversion of warrants. This acquisition is disclosed per SAST regulations.
Swojas Foods Other Announcement
Swojas Foods Ltd filed its quarterly shareholding pattern as required by SEBI regulations. This routine disclosure involves no material business transactions or corporate events.
Swojas Foods Capital Structure Change
Swojas Foods approved conversion of 24,25,000 warrants into equity shares for Onelife Capital. The ₹3.00 Crore balance payment increases paid-up capital to ₹482.88 Cr.
- Value
- ₹3.00 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.